type 2 diabetes

SGLT-2 Inhibitors Outperform in Diabetes Care An insightful doctor prescribing advanced treatments for type 2 diabetes, comparing various drug therapies in a clinical setting. Emphasis on SGLT-2 inhibitors, with medical charts showing lower blood sugar levels and improvements in heart and kidney health. A scene showing patient progress with cutting-edge diabetes management.

SGLT-2 Inhibitors Outperform in Diabetes Care

Contributor September 25, 2024

This study compares the effectiveness of second-line oral antidiabetic treatments in people with type 2 diabetes. SGLT-2...

Cutting Potassium Risk: A Breakthrough for Diabetes Patients High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

Cutting Potassium Risk: A Breakthrough for Diabetes Patients

Contributor September 23, 2024

This population-based cohort study investigates the relationship between the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and...

Unlocking Hidden Risks: Fatty Liver and Heart Disease in Diabetes Depicting a patient with type 2 diabetes, focusing on the heart and liver to represent cardiovascular disease and non-alcoholic fatty liver disease.

Depicting a patient with type 2 diabetes, focusing on the heart and liver to represent cardiovascular disease and non-alcoholic fatty liver disease.

Unlocking Hidden Risks: Fatty Liver and Heart Disease in Diabetes

Contributor September 20, 2024

This study investigates the relationship between non-alcoholic fatty liver disease (NAFLD) and the risk of cardiovascular disease...

Unlock Superior Diabetes Control: Boost Health & Confidence An advanced medical illustration showcasing the mechanism of GLP-1 receptor agonists in type 2 diabetes treatment. The image should depict a vibrant scientific scene with blood sugar regulation, weight loss, and lipid improvement visual cues, all in a clinical setting.

Unlock Superior Diabetes Control: Boost Health & Confidence

Contributor September 18, 2024

This systematic review and meta-analysis evaluates the comparative effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for glycemic...